Advertisement

Maquet offers their FUSION Bioline heparin-coated vascular grafts, which the company feels merges the benefits of ePTFE and PET with a unique heparin coating to enhance graft performance and address surgeon needs. The dual-layer construction with heparin coating sets a new standard for open peripheral bypass treatment with enhanced handling, thrombo-resistance and minimal suture hole bleeding. According to Maquet, FUSION Bioline is the only FDA 510k-cleared peripheral graft with a RCT demonstrating improved patency and fewer graft re-interventions, when compared to standard ePTFE grafts, as shown in FINEST trial results.

Advertisement
Advertisement